Randomisation
CORONARY ARTERY DISEASE
Following consent, patients will be randomised (1:1), either to CTCA plus standard of care or standard of care alone. Randomisation will be conducted using a web-based computer-generated system to ensure allocation concealment, stratified by age (< 70 years versus ≥ 70 years), sex, site and previously diagnosed coronary artery disease. This is an open-label trial design, and the patient and clinical care team will not be blinded to the intervention. Once randomised, a letter will be sent to the participant’s general practitioner (GP) to inform them of their involvement in the study.